Haleon Plc: 2026 Half Year Results Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the half-year period ending 31 December 2026, with results announced on 30 July 2026. Haleon is a consumer health company focused on everyday health across six categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing serves as a notice that the full half-year results statement is available via the London Stock Exchange, the company website, and the FCA National Storage Mechanism.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced "2026 Half Year Results" statement but are not detailed in this summary document.
Material Changes and Dividend Declaration
The Board has declared an interim dividend for H1 2026 of 2.4 pence per ordinary share. This represents a 9% increase compared to the interim dividend paid in 2025. The dividend is consistent with the company's policy to pay approximately one-third of the prior year's full-year dividend as the interim payment.
Guidance, Outlook, and Management Commentary
Management expects to grow the ordinary dividend at least in line with adjusted earnings, subject to market conditions and Board approval. A recorded results presentation and Q&A session featuring CEO Brian McNamara and CFO Dawn Allen were scheduled for 30 July 2026. The filing does not contain specific forward-looking revenue guidance or detailed risk factors beyond the standard market condition caveat regarding dividends.
Investor Verification Checklist
- Verify the full financial performance metrics (revenue, profit, cash flow) in the attached "2026 Half Year Results" statement (Exhibit 99.1).
- Confirm the ex-dividend dates: 13 August 2026 for ordinary shareholders and 14 August 2026 for ADS holders.
- Note the dividend payment date of 17 September 2026 and the DRIP election deadline of 28 August 2026.
- Review the management presentation for details on adjusted earnings growth and category-specific performance.